Read more from the original source:
Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End
Author Archives: Fredricko
Acasti Announces Court Dismissal of Stockholder Litigation
Arvinas Gives Back to Local Greater New Haven Community
See the original post here:
Arvinas Gives Back to Local Greater New Haven Community
Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform
Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA
AB Science today reports its revenues for the first half of 2022 and provides an update on its activities
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Total number of shares and voting rights in Zealand Pharma at September 30, 2022
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR…
Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-vec (ADVM-022) in…
Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3
Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the…
Belite Bio Presented 12-Month Interim Results of LBS-008 Phase 1b/2 Study in Adolescent Stargardt Disease at AAO Annual Meeting 2022
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
Go here to see the original:
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin’s Effect on Reducing Recurrent Heart Failure Events
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to…
Idorsia Japan announces positive results with daridorexant in a Phase 3 study of Japanese patients with insomnia
Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHD
Santhera Submits Marketing Authorization Application to the European Medicines Agency for Vamorolone in Duchenne Muscular Dystrophy
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines
Go here to read the rest:
Bavarian Nordic Enters Agreement with Country in Latin America on the Supply of Monkeypox Vaccines